XTL Biopharmaceuticals(XTLB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XTLB XTL Biopharmaceuticals

Market Closed 02-06 16:00:00 EST

1.07

+0.01

+0.94%

盘后1.07

+0.000.00%

17:23 EST

High1.08	Low0.9804	Vol38.30K
Open0.9804	D1 Closing1.06	Amplitude9.40%
Mkt Cap10.12M	Tradable Cap5.53M	Total Shares9.46M
T/O39.18K	T/O Rate0.74%	Tradable Shares5.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"XTL Biopharmaceuticals","latestPrice":1.07,"timestamp":1770411600000,"preClose":1.06,"halted":0,"volume":38304,"hourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.07,"latestTime":"17:23 EST","volume":89,"amount":91.34,"timestamp":1770416607381,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.009433962264150952,"floatShares":5167500,"shares":9462400,"eps":-1.1996,"marketStatus":"Market Closed","change":0.01,"latestTime":"02-06 16:00:00 EST","open":0.9804,"high":1.08,"low":0.9804,"amount":39181.2841728,"amplitude":0.093962,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.1996,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":100,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":0.98,"preClose":1.06,"latestTime":"09:00 EST","volume":351,"amount":346.7659221,"timestamp":1770386431867,"change":-0.08,"changeRate":-0.075472,"amplitude":0.009151},"postHourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.07,"latestTime":"17:23 EST","volume":89,"amount":91.34,"timestamp":1770416607381,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3597149948936976},"requestUrl":"/m/hq/s/XTLB/tweets","defaultTab":"tweets","newsList":[{"id":"2606371755","title":"XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2606371755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606371755?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:17","pubTimestamp":1769609841,"startTime":"0","endTime":"0","summary":"The latest announcement is out from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ). On January 28, 2026, XTL Biopharmaceuticals Ltd. announced it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","XTL","BK4588","BK4139","BK4215","BK4585","XTLB","NQmain"],"gpt_icon":0},{"id":"2605612286","title":"XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605612286?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:11","pubTimestamp":1769206267,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) just unveiled an update. On January 23, 2026, XTL Biopharmaceuticals reported that its wholly owne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTL","XTLB"],"gpt_icon":0},{"id":"2605286646","title":"XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286646","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605286646?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:10","pubTimestamp":1769206256,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has provided an announcement. On January 23, 2026, XTL Biopharmaceuticals disclosed that it receiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTLB","BK4139","EQR","BK4588","BK4585","XTL","BK4215","NQmain"],"gpt_icon":0},{"id":"2605285567","title":"XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2605285567","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605285567?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:10","pubTimestamp":1769202600,"startTime":"0","endTime":"0","summary":"RAMAT GAN, ISRAEL, Jan.  23, 2026  (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/23/3225065/0/en/XTL-Announces-Receipt-of-Nasdaq-Notification-Regarding-Minimum-Stockholders-Equity-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","BK4215","BK4139","EQR","BK4585","91348","SLE","BK4588","XTL","XTLB"],"gpt_icon":0},{"id":"2603865846","title":"ADRs Hold Steady; XTL Biopharmaceuticals Ltd. Climbs 57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603865846","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603865846?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:30","pubTimestamp":1768339800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed flat on Tuesday, as the S&P/BNY Mellon index of American depositary receipts was flat at 248.92.The European index added 0.1% to 219.06. The Asian index declined 0.1% to 333.23. The Latin American index rose 0.2% to 247.81, while the emerging-markets index dropped 0.3% to 557.38.Israel's XTL Biopharmaceuticals Ltd. was the biggest leader during the session, soaring 57% to $1.07, and China-based 111 Inc. rocketed 37% to $5.00. Immuron Ltd., which is based in Australia, rounded out the top three leaders on Tuesday, with shares rocketing 23% to $1.20.Zepp Health Corp., based in China, posted the largest decline, plunging 15% to $22.81, followed by shares of India's Sify Technologies Ltd., which plunged 14% to $12.94. Shares of China-based MOGU Inc. plunged 11% to $2.00.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTL","BK4139","XTLB"],"gpt_icon":0},{"id":"2603638752","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:49 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2603638752","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603638752?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:49","pubTimestamp":1768315771,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:49 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nAQN2LHI1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2603968077","title":"XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968077","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603968077?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:28","pubTimestamp":1768314480,"startTime":"0","endTime":"0","summary":"Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/13/3217924/0/en/XTL-Biopharmaceuticals-Acquires-85-of-NeuroNOS-Entering-the-Massive-Autism-Market-with-Nobel-Prize-Winning-Scientific-Leadership.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","XTLB","XTL","BK4077","XAIR","SLE"],"gpt_icon":0},{"id":"2603681455","title":"XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681455","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603681455?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:58","pubTimestamp":1768309114,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has shared an announcement. On January 13, 2026, XTL Biopharmaceuticals Ltd. signed a binding lett...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-moves-to-acquire-neuronos-stake-from-beyond-air-and-plans-2-million-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-moves-to-acquire-neuronos-stake-from-beyond-air-and-plans-2-million-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","XTLB","BK4139"],"gpt_icon":0},{"id":"2574191259","title":"ADRs Close Lower; XTL Biopharmaceuticals Ltd. Declines 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574191259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574191259?lang=en_us&edition=fundamental","pubTime":"2025-10-10 04:30","pubTimestamp":1760041800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed lower on Thursday, as the S&P/BNY Mellon index of American depositary receipts dropped 1.4% to 228.63.The European index dropped 1.2% to 197.51. The Asian index declined 1.6% to 315.00. The Latin American index dropped 0.3% to 211.89, while the emerging-markets index dropped 1.7% to 524.65.XTL Biopharmaceuticals Ltd., based in Israel, posted the largest decline, plunging 16% to $1.73, followed by shares of Israel's Scinai Immunotherapeutics Ltd., which dropped 9.2% to $1.48. Shares of United Kingdom-based Argo Blockchain PLC dropped 8.5% to 61 cents.China's Ambow Education Holding Ltd. was the biggest leader during the session, soaring 61% to $5.75, and China-based 9F Inc. soared 58% to $4.35. Biodexa Pharmaceuticals PLC, which is based in United Kingdom, rounded out the top three leaders on Thursday, with shares soaring 40% to $10.81.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XTL","XTLB"],"gpt_icon":0},{"id":"2573928451","title":"Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928451?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:01","pubTimestamp":1759924882,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks are soaring on Wednesday in what appears to be a continuation of yesterday’s speculative trading for Galecto.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-are-pharmaceutical-stocks-xbio-upc-xtlb-acxp-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-are-pharmaceutical-stocks-xbio-upc-xtlb-acxp-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","XTLB","XBIO","UPC","BK4539","BK4563","ACXP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":0.2566},{"period":"1month","weight":0.621},{"period":"3month","weight":0.07},{"period":"6month","weight":-0.2132},{"period":"1year","weight":-0.3352},{"period":"ytd","weight":0.8448}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.121456},{"month":2,"riseRate":0.411765,"avgChangeRate":-0.018234},{"month":3,"riseRate":0.375,"avgChangeRate":0.154077},{"month":4,"riseRate":0.4375,"avgChangeRate":-0.01928},{"month":5,"riseRate":0.266667,"avgChangeRate":-0.059048},{"month":6,"riseRate":0.466667,"avgChangeRate":0.000234},{"month":7,"riseRate":0.4375,"avgChangeRate":0.469627},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.037628},{"month":9,"riseRate":0.1875,"avgChangeRate":-0.076581},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.025328},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.062792},{"month":12,"riseRate":0.235294,"avgChangeRate":-0.064989}],"exchange":"NASDAQ","name":"XTL Biopharmaceuticals","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XTL Biopharmaceuticals(XTLB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest XTL Biopharmaceuticals(XTLB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"XTL Biopharmaceuticals,XTLB,XTL Biopharmaceuticals股票,XTL Biopharmaceuticals股票老虎,XTL Biopharmaceuticals股票老虎国际,XTL Biopharmaceuticals行情,XTL Biopharmaceuticals股票行情,XTL Biopharmaceuticals股价,XTL Biopharmaceuticals股市,XTL Biopharmaceuticals股票价格,XTL Biopharmaceuticals股票交易,XTL Biopharmaceuticals股票购买,XTL Biopharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XTL Biopharmaceuticals(XTLB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest XTL Biopharmaceuticals(XTLB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction